Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

OBJECTIVE: To describe how maintenance eculizumab sustains improved renal function in severe atypical hemolytic uremic syndrome (aHUS). CASE REPORT: A previously described 50-year-old woman with aHUS had a remarkable recovery with eculizumab, which safely reversed profound neurologic damage and elim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohanian, Maro, Cable, Christian, Halka, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262388/
https://www.ncbi.nlm.nih.gov/pubmed/22287856
http://dx.doi.org/10.2147/CPAA.S23687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262388/
https://www.ncbi.nlm.nih.gov/pubmed/22287856
http://dx.doi.org/10.2147/CPAA.S23687

Ejemplares similares